TSC Life Receives FDA 510(K) Clearance for Fluido® AirGuard System, a Moderate to High Flow Blood and IV Fluid Warming Solution for the Prevention of Hypothermia

DENVER, Sept. 24, 2025 /PRNewswire/ -- TSC Life announces FDA clearance of its moderate to high flow blood and fluid warmer, Fluido® AirGuard System, in the U.S.

In emergency care, surgery, ICU, labor and delivery, and severe trauma cases, the quick administration of warm IV fluids or blood products is crucial. Two-thirds of trauma patients are already suffering from mild hypothermia by the time they enter the emergency room. Just one unit of refrigerated blood or one liter of crystalloid at room temperature can reduce mean body temperature by 0.45° F.

The Fluido® AirGuard System combines rapid infusion with enhanced patient safety features for expedited care of these patients, protecting them during high flow blood and IV-fluid infusions. One such risk is outgassing—the release of dissolved gasses such as air when fluids are warmed. Outgassing can form bubbles that enter the bloodstream and may block blood flow, leading to serious complications such as stroke, heart attack, or even death. Fluido™ AirGuard System features automatic air detection and IV-line clamping to prevent air bubbles from entering the bloodstream.

Sign up for Blog Updates